Prophylactic tropisetron versus rescue tropisetron in fractionated radiotherapy to moderate or high emetogenic areas: A prospective randomized open label study in cancer patients

Medical Oncology

Volumn 23, Issue 2, 2006, Pages 251-262

  Mystakidou, K ^a   Katsouda, E ^a   Linou, A ^b   Parpa, E ^a   Kouloulias, V ^b   Nikolaou, V ^c   Vlahos, L ^b  

^a UNIVERSITY OF ATHENS   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c Institute of Preventive Medicine Prolipsi   (Greece)

Author keywords

Cancer patients; Prophylactic antiemetic therapy; Radiation induced emesis (RIE); Tropisetron

Indexed keywords

TROPISETRON;

ADULT; AGED; ANOREXIA; ARTICLE; BREAST CANCER; CANCER PATIENT; CANCER RADIOTHERAPY; CHEMOTHERAPY INDUCED EMESIS; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG SAFETY; EXTRAPYRAMIDAL SYMPTOM; FATIGUE; FEMALE; FEVER; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA; OVARY CANCER; PANCREAS CANCER; PRIORITY JOURNAL; RADIATION INJURY; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SAMPLE; STATISTICAL SIGNIFICANCE;

AGED; ANTIEMETICS; DOSE FRACTIONATION; FEMALE; HUMANS; INDOLES; MALE; MIDDLE AGED; NAUSEA; NEOPLASMS; PROSPECTIVE STUDIES; VOMITING;

EID: 33646891972     PISSN: 13570560     EISSN: None     Source Type: Journal    
DOI: 10.1385/MO:23:2:251     Document Type: Article

References (19)

1. The Italian Group for Antiemetic Research in Radiotherapy. Radiation-induced emesis: a prospective observational multicenter Italian trial. Int J Radiation Oncology Biol Phys 1999; 44(3): 619-625.
2. Roila F, Ciccaverse G, Palladino MA. Prevention of radiotherapy induced emesis. Tumori 1998; 84: 274-278.
3. Priestman TJ, Priestman SG. Clinical trials in the prevention and control of emesis induced by therapeutic radiation. Colloque Inserm 1992; 223: 157-165.
4. Anno GH, Baum SJ, Withers HR, Young RW. Symptomatology of acute radiation effects in humans after exposure to doses 0.5-30 Gy. Health Physiol 1989; 56: 821-838.
5. Feyer P. Ondansetron in radiotherapy-induced emesis. J Pharmacol Ther 1995; 4: 112-113.
6. Priestman TJ, Roberts JT, Upadhyaya BK. Randomized double-bind trial of ondansetron and prochlorperazine in the prevention of fractionated radiotherapy. Proc Am Soc Clin Oncol 1992; 9: 1370.
7. Priestman TJ, Roberts JT, Upadhyaya BK. A prospective randomized double-blind trial comparing ondansetron versus prochlorperazine for the prevention of nausea and vomiting in pts undergoing fractionated radiotherapy. Clin Oncol 1993; 5: 358-363.
8. Roberts JT, Priestman TJ. A review of ondansetron in the management of radiotherapy induced emesis. Oncology 1993; 50: 173-179.
9. Alman DG, Dore CJ. Randomisation and baseline comparisons in clinical trials. Lancet 1990; 335: 149-153.
10. Cunnigham D, et al. Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorourasil failure for patients with metastatic colorectal cancer. Lancet 1998; 352: 1413-1418.
11. Brown CH, Liao J. Principles for designing randomized preventive trials in mental health: an emerging developmental epidemiology paradigm. Am J Community Psychol 1999; 27(5): 673-710.
12. Sorbe B, et al. Efficacy and tolerability with a combination of tropisetron and dexamethasone in the control of nausea and vomiting induced by cisplatin-containing chemotherapy. Eur J Cancer 1994; 30A: 629-634.
13. Franklin HR, et al. Toxicity grading systems. A comparison between the WHO scoring system and the Common Toxicity Criteria when used for nausea and vomiting. Ann Oncol 1994; 5: 113-117.
14. Olver IN. Methodology of anti-emetic trials. Oncology 1992; 49: 269-272.
15. Feyer PC. Incidence of emesis and nausea in fractionated radiotherapy patients. In advances in optimizing the control of emesis. Satellite Symposium to ESMO, Lisbon, November 1994.
16. Heron JF. Single-agent oral granisetron for the prevention of acute cisplatin-induced emesis: a double-blind, randomized comparison with granisetron plus dexamethasone and high-dose metoclopramide plus dexamethazone. Semin Oncol 1995; 22 (suppl 10): 24-30.
17. Perez EA. Overview: oral granisetron (Kytril tablets) prophylaxis for chemotherapy-induced nausea and vomiting. Semin Oncol 1995; 22 (suppl 10): 1-2.
18. Gralla RJ, et al. A unique all-oral, single-dose, combination antiemetic regimen with high efficacy and marked cost saving potential. Proc Am Soc Clin Oncol 1995; 14: 526 (abstr 1730).
19. Mystakidou K, Befon S, Liossi C, Vlahos L. Comparison of the efficacy and safety of tropisetron, metoclopramide, and chlorpromazine in the treatment of emesis associated with far advanced cancer. Cancer 1998, 83(6): 1214-1223.